Key result
Synthetic KCNQ channel openers, specifically zinc pyrithione plus retigabine, restored KCNQ4 currents to wild-type levels in dominant-negative DFNA2 mutant models.
Chemical channel openers like zinc pyrithione and retigabine can restore KCNQ4 channel function in certain DFNA2 mutations, suggesting a potential therapeutic strategy for progressive hearing loss.
Answers are grounded in this paper and cite their sources.
May support KCNQ openers for DFNA2 hearing loss; hypothesis-generating from animal models only.
BACKGROUND AND PURPOSE: DFNA2 is a frequent hereditary hearing disorder caused by loss-of-function mutations in the voltage-gated potassium channel KCNQ4 (Kv7.4). KCNQ4 mediates the predominant K(+) conductance, I(K,n) , of auditory outer hair cells (OHCs), and loss of KCNQ4 function leads to degeneration of OHCs resulting in progressive hearing loss. Here we explore the possible recovery of channel activity of mutant KCNQ4 induced by synthetic KCNQ channel openers. EXPERIMENTAL APPROACH: Whole cell patch clamp recordings were performed on CHO cells transiently expressing KCNQ4 wild-type (wt) and DFNA2-relevant mutants, and from acutely isolated OHCs. KEY RESULTS: Various known KCNQ channel openers robustly enhanced KCNQ4 currents. The strongest potentiation was observed with a combination of zinc pyrithione plus retigabine. A similar albeit less pronounced current enhancement was observed with native I(K,n) currents in rat OHCs. DFNA2 mutations located in the channel's pore region abolished channel function and these mutant channels were completely unresponsive to channel openers. However, the function of a DFNA2 mutation located in the proximal C-terminus was restored by the combined application of both openers. Co-expression of wt and KCNQ4 pore mutants suppressed currents to barely detectable levels. In this dominant-negative situation, channel openers essentially restored currents back to wt levels, most probably through strong activation of only the small fraction of homomeric wt channels. CONCLUSIONS AND IMPLICATIONS: Our data suggest that by stabilizing the KCNQ4-mediated conductance in OHCs, chemical channel openers can protect against OHC degeneration and progression of hearing loss in DFNA2.
No takes yet. Share an insight, caveat, or question.
Leitner et al. (2011) studied DFNA2 (hereditary hearing disorder). Synthetic KCNQ channel openers (zinc pyrithione plus retigabine) was evaluated on KCNQ4 current enhancement and channel function restoration. Synthetic KCNQ channel openers, specifically zinc pyrithione plus retigabine, restored KCNQ4 currents to wild-type levels in dominant-negative DFNA2 mutant models.
Synapse has enriched 10 related papers. Consider them for comparative context: